期刊文献+

超声引导下选择性门静脉栓塞在肝癌二期切除中的应用 被引量:5

Effect of uitrasonic-guided selective portal vein embolization on the two-stage hepatotectomy of patients with primary hepatocellular carcinoma.
下载PDF
导出
摘要 目的 探讨超声引导下经皮经肝细针穿刺术前选择性门静脉栓塞 (POSPVE)后对不宜手术切除的肝细胞性肝癌 (HCC)二期切除的可能性。 方法  32例不宜手术切除的HCC患者行超声引导下经皮经肝细针穿刺POSPVE ,观察手术成功率及术后不良反应、各肝叶体积及预计肝切除率的动态变化、二期手术切除率等指标。 结果 手术成功 30例 (93.8% ) ,右侧门静脉支栓塞后右肝体积逐步减少 ,左肝体积逐步增大 ,术前、术后 1w、2w、3w时的预计肝切除率分别为 6 6 .6 %、6 5 .5 %、6 2 .9%、6 0 6 %。术后 2 6例出现不同程度的肝区隐痛 (2 6例 )、低热 (19例 )、恶心呕吐 (7例 )。有程度不同的肝功能减退 ,AST由术前 (44 .6± 5 .3)IU/L ,至术后 1d (5 6 .2± 7.6 )IU/L ,术后 3d (5 1.4± 5 .5 )IU/L ;ALT由术前(5 8.4± 7.4 )IU/L ,至术后 1d (6 2 .8± 9.6 )IU/L ,术后 3d (6 0 .2± 8.5 )IU/L ;TBIL由术前 (14 .6± 5 .3) μmol/L至术后 1d (19.1± 8.6 ) μmol/L ,术后 3d (17.4± 7.7) μmol/L ;PT由术前 (82 .6± 6 .3) % ,至术后 1d (78.6±8.2 ) % ,术后 3d (75 .3± 6 .4 ) %。术后 2w - 4w ,14例 (43.8% )完成了肝癌二期肝切除手术。 结论 超声引导下经皮经肝细针穿刺POSPVE简便易行 。 Objective To study the possibility of ultrasonic-guided preoperative selective portal vein embolization(POSPVE)in the two-stage hepatectomy of primary hepatocellular carcinoma(HCC). Methods 32 patients with HCC who were not suitable for hepatectomy were treated by ultrasonic-guided percuteneous trans hepatic POSPVE with fine needle,hepatectomy rate after the treatment were observed. Results Ultrasonic-guided POSPVE were successively performed in 30 patients(93.8%).In patients with embolized right portal vein branch right liver volume decreased and left liver volume increased gradually.The estimated rarate of hepatectomy decreased from 66.6% before POSPVE to 65.5% after 1w,62.9% after 2w and 60.6%(19/39).The adverse reaction included different degree of pain ofliver area(26/30),lower fever(19/39),nausea and vomiting(7/30).The level of aspartate alanine transaminase increased from (44.6±5.3)IU/L before POSPVE to (56.2±7.6)IU/L after 1d and (51.4±5.5)IU/L after 3d;The level of alanine transaminase increased from (58.4±7.4)IU/Lbefore POSPVE to (62.8±9.6)IU/Lafter 1d and (60.2±8.5)IU/L after 3d;The level of total bilirubin was (14.6±5.3)μmol/L before POSPVE to (19.1±8.6)μmol/L after 1d and (17.4±7.7)μmol/L after 3d;The level of prothrombin time was (82.6±6.3)% before POSPVE to (78.6±8.2)% after 1d and (75.3±6.4)% after 3d.After 2w-4w two-stage hepatectomy for HCC were successively performed in 14(43.8%)patients. Conclusions Ultrasonic-guided percuteneous transhepatic POSPVE extends the indication of hepatectomy of HCC,increase the security of hepatectomy.
出处 《中国微创外科杂志》 CSCD 2002年第2期88-91,共4页 Chinese Journal of Minimally Invasive Surgery
关键词 门静脉栓塞 二期切除 肝细胞性肝癌 超声引导 经皮肝细针穿刺术 portal vein embolization two-stage hepatectomy primary hepatocellular carcinoma ultrasonography
  • 相关文献

参考文献13

  • 1Shimamura T,Nakajima Y,et al.Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol:a clinical study.Surgery,1997,121:135-141.
  • 2Azoulay D,Castaing D,Smail A,et al.Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.Ann Surg,2000,231:480-486.
  • 3Kinoshita H,Sakai K,Hirohashi K,et al.Preoperative portal vein embolization for hepatocellular carcinoma.World J Surg,1986,10:803-8.
  • 4Tanaka H,Hirohashi K,Kubo S,et al.Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function.Br J Surg,2000,87:879-82.
  • 5Harada H,Imamura H,Miyagawa S,et al.Fate of the human liver after hemihepatic portal vein embolization;cell kinetic and morphometric study.Hepatology,1997,26:1162-1170.
  • 6Chijiiwa K,Saiki S,Noshiro N,et al.Effect of preoperative portal vein embolization on liver volume and hepatic energy status of the nonembolized liver lobe in humans.Eur Surg Res,2000,32:94-99.
  • 7Shimizu Y,Suzuki H,Nimura Y,et al.Elevated mitochondrial gene expression during rat liver regeneration after portal vein ligation.Hepatology,1995,22:1222-1229.
  • 8Lee KC,Kinoshita H,Hirohashi K,et al.Extension of surgical indication for hepatocellular carcinoma by portal vein embolization.World J Surg,1993,17:109-115.
  • 9Tsuge H,Mimura H,Kawata N,et al.Right portal vein embolization before extended right hepatectomy using laparoscopic catheterization of the ileocolic vein;a prospective study.Surg Laparosc Endosc,1994,4:258.
  • 10De Baere T,Roche A,Elias D,et al.Preoperation portal vein embolization for extension of hepatectomy indications.Hepatology,1996,24:1386-1391.

同被引文献101

  • 1王洪波,周宁新,李志伟,张培瑞,张效东,张珂,纪旭,赵景民,周光德.门脉高压症患者脾切除术后免疫功能的改变及其与脾组织免疫细胞的关系[J].消化外科,2004,3(4):286-290. 被引量:22
  • 2张曦彤,徐克,张汉国,张连成,赵钟春,韩铭钧.原发性肝癌伴门脉高压的TIPSS治疗[J].临床放射学杂志,1995,14(4):236-238. 被引量:11
  • 3李建军,杨维竹,江娜,黄兢姚,郑曲彬,黄宁,杨升.经导管门静脉栓塞诱导肝叶代偿性增生的临床应用研究[J].中华放射学杂志,2006,40(2):186-190. 被引量:4
  • 4陈健,王曙光.门静脉栓塞的临床应用进展[J].中华消化外科杂志,2007,6(1):74-77. 被引量:1
  • 5Okamoto E,Kyo A,Yamanaka N,et al.Prediction of the safe limits of hepatectomy by combined volumetric and functional measurement in patients with impaired hepatic function.Surgery,1984,95:586-592.
  • 6Lee KC,Kinoshita H,Hirohashi K,et al.Extension of surgical indications for hepatocellular carcinoma by portal vein embolization.World J Surg,1993,17:109-115.
  • 7Imamura H,Shimada R,Kubota M,et al.Preoperative portal vein embolization:an audit of 84 patients.Hepatology,1999,29:1099-1105.
  • 8Madoff DC,Hicks ME,Abdalla EK,et al.Portal vein embolization with polyvinyl alcohol particles and coils in preparation for hepatobiliary malignancy:safty and effectiveness-study in 26 patients.Radiology,2003,227:251-260.
  • 9Sugai Y,Komatani A,Hosoya T,et al.Response to precutaneous transhepatic portal embolization:new proposed parameters by 99mTc-GSA SPECT and their usefulness in prongostic estimation after hepatectomy.J Nucl Med,2000,41:421-425.
  • 10Vauthey JN,Chaoui A,Do KA,et al.Standardized measurement of the future liver remnant prior to extended liver resection:methodology and clinical associations.Surgery,2000,127:512-519.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部